Projects per year
Abstract
BACKGROUND AND PURPOSE: Dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channel causes the genetic disease cystic fibrosis (CF). Towards the development of transformational drug therapies for CF, we investigated the channel function and action of CFTR potentiators on A561E, a CF mutation found frequently in Portugal. Like the most common CF mutation F508del, A561E causes a temperature-sensitive folding defect that prevents CFTR delivery to the cell membrane and is associated with severe disease.
EXPERIMENTAL APPROACH: Using baby hamster kidney (BHK) cells expressing recombinant CFTR, we investigate CFTR expression by cell surface biotinylation, and function and pharmacology with the iodide efflux and patch-clamp techniques.
KEY RESULTS: Low temperature incubation delivered a small proportion of A561E-CFTR protein to the cell surface. Like F508del-CFTR, low temperature-rescued A561E-CFTR exhibited a severe gating defect characterized by brief channel openings separated by prolonged channel closures. A561E-CFTR also demonstrated thermoinstability, losing function more quickly than F508del-CFTR in cell-free membrane patches and intact cells. Using the iodide efflux assay, CFTR potentiators, including genistein and the clinically-approved small-molecule ivacaftor, restored partial function to A561E-CFTR. Interestingly, ivacaftor restored wild-type levels of channel activity (as measured by open probability) to single A561E- and F508del-CFTR Cl(-) channels. However, it accentuated the thermoinstability of both mutants in cell-free membrane patches.
CONCLUSIONS AND IMPLICATIONS: Like F508del-CFTR, A561E-CFTR perturbs protein processing, thermostability and channel gating. CFTR potentiators partially restore channel function to low temperature-rescued A561E-CFTR. Transformational drug therapy for A561E-CFTR will likely require CFTR correctors, CFTR potentiators and special attention to thermostability.
Original language | English |
---|---|
Journal | British Journal of Pharmacology |
DOIs | |
Publication status | Published - 5 Jun 2014 |
Bibliographical note
This article is protected by copyright. All rights reserved.Fingerprint
Dive into the research topics of 'CFTR potentiators partially restore channel function to A561E, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR'. Together they form a unique fingerprint.Projects
- 2 Finished
-
Synthetic Anionophores with Therapeutic Potential - a Coordinated Two-Centre Approach
Davis, A. P. (Principal Investigator)
10/09/12 → 9/03/16
Project: Research
-
SYNTHETIC ANION CARRIERS FOR BIOMEDICAL APPLICATIONS
Davis, A. P. (Principal Investigator)
1/11/08 → 1/03/12
Project: Research